IL17A and Stroke: In conclusion, LIPUS improves long-term functional recovery by ameliorating the inflammatory state after stroke and inhibiting IL-17A/Notch1 signaling to promote WM repair, which provides a promising novel therapeutic approach for stroke and other demyelinating diseases.